Occurrence of neuronal inclusions combined with increased nigral expression of α-synuclein within dopaminergic neurons following treatment with amphetamine derivatives in mice-Reference-Cited by-同舟云学术

Occurrence of neuronal inclusions combined with increased nigral expression of α-synuclein within dopaminergic neurons following treatment with amphetamine derivatives in mice

Published:2005-05 Issue:5 Volume:65 Page:405-413
ISSN:0361-9230
Container-title:Brain Research Bulletin
language:en
Short-container-title:Brain Research Bulletin

Author:

Fornai Francesco,Lenzi Paola,Ferrucci Michela,Lazzeri Gloria,Poggio Adolfo Bandettini di,Natale Gianfranco,Busceti Carla L.,Biagioni Francesca,Giusiani Mario,Ruggieri Stefano,Paparelli Antonio

Publisher

Elsevier BV

Subject

General Neuroscience

Reference41 articles.

1. Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents;Albers;J. Pharmacol. Exp. Ther.,1995

2. Methamphetamine-induced dopaminergic toxicity in mice. Role of environmental temperature and pharmacological agents;Ali;Ann. N. Y. Acad. Sci.,1996

3. The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum;Bowyer;J. Pharmacol. Exp. Ther.,1992

4. Alpha-synuclein immunoreactivity of huntingtin polyglutamine aggregates in striatum and cortex of Huntington's disease patients and transgenic mouse models;Charles;Neurosci. Lett.,2000

5. Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct;Conway;Science,2001

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Repeated Methamphetamine Administration Results in Axon Loss Prior to Somatic Loss of Substantia Nigra Pars Compacta and Locus Coeruleus Neurons in Male but Not Female Mice;International Journal of Molecular Sciences;2023-08-22

2. Early Diagnosis of Parkinson’s Disease: Utility of Animal Models;Parkinson’s Disease - Animal Models, Current Therapies and Clinical Trials [Working Title];2022-11-11

3. Methamphetamine induced neurotoxic diseases, molecular mechanism, and current treatment strategies;Biomedicine & Pharmacotherapy;2022-10

4. A Scientometric Visualization Analysis for Molecular Mechanisms of Substance Abuse and Its Neurotoxicity From 1997 to 2021;Frontiers in Molecular Neuroscience;2022-07-01

5. Alpha-Synuclein Toxicity: An Insight on Controversial Issues;Handbook of Neurotoxicity;2022